 | • レポートコード：MRC2012A4677 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ヒトインスリンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒトインスリンの種類別市場規模（インスリンアナログ・バイオシミラー、ヒトインスリン生物学）、用途別市場規模（短時間作用型、中型作用型、長時間作用型、プレミックスインスリン）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：B. Braun、Sanofi、Biodel、Becton, Dickinson、NOVO Nordisk、Biocon、Ypsomed、Julphar、ELI Lilly、Wockhardt、 ・地域別グローバル市場分析 2015年-2020年 ・ヒトインスリンの北米市場（アメリカ、カナダ、メキシコ） ・ヒトインスリンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒトインスリンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒトインスリンの南米市場（ブラジル、アルゼンチン） ・ヒトインスリンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：インスリンアナログ・バイオシミラー、ヒトインスリン生物学 ・用途別分析：短時間作用型、中型作用型、長時間作用型、プレミックスインスリン ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Human Insulin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Human Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Human Insulin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Insulin market has been segmented into
Insulin Analogs and Biosimilars
Human Insulin Biologics
By Application, Human Insulin has been segmented into:
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Insulin market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Insulin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Insulin market.
The report offers in-depth assessment of the growth and other aspects of the Human Insulin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Insulin Market Share Analysis
Human Insulin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Insulin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Insulin sales, revenue and market share for each player covered in this report.
The major players covered in Human Insulin are:
B. Braun
Sanofi
Biodel
Becton, Dickinson
NOVO Nordisk
Biocon
Ypsomed
Julphar
ELI Lilly
Wockhardt
Among other players domestic and global, Human Insulin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Insulin, with price, sales, revenue and global market share of Human Insulin in 2018 and 2019.
Chapter 3, the Human Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Human Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Insulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Insulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Short acting
1.3.3 Intermediate acting
1.3.4 Long acting
1.3.5 Pre-mix Insulin
1.4 Overview of Global Human Insulin Market
1.4.1 Global Human Insulin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 B. Braun
2.1.1 B. Braun Details
2.1.2 B. Braun Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 B. Braun SWOT Analysis
2.1.4 B. Braun Product and Services
2.1.5 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biodel
2.3.1 Biodel Details
2.3.2 Biodel Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biodel SWOT Analysis
2.3.4 Biodel Product and Services
2.3.5 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Becton, Dickinson
2.4.1 Becton, Dickinson Details
2.4.2 Becton, Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Becton, Dickinson SWOT Analysis
2.4.4 Becton, Dickinson Product and Services
2.4.5 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 NOVO Nordisk
2.5.1 NOVO Nordisk Details
2.5.2 NOVO Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 NOVO Nordisk SWOT Analysis
2.5.4 NOVO Nordisk Product and Services
2.5.5 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biocon
2.6.1 Biocon Details
2.6.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biocon SWOT Analysis
2.6.4 Biocon Product and Services
2.6.5 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ypsomed
2.7.1 Ypsomed Details
2.7.2 Ypsomed Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ypsomed SWOT Analysis
2.7.4 Ypsomed Product and Services
2.7.5 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Julphar
2.8.1 Julphar Details
2.8.2 Julphar Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Julphar SWOT Analysis
2.8.4 Julphar Product and Services
2.8.5 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 ELI Lilly
2.9.1 ELI Lilly Details
2.9.2 ELI Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 ELI Lilly SWOT Analysis
2.9.4 ELI Lilly Product and Services
2.9.5 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Wockhardt
2.10.1 Wockhardt Details
2.10.2 Wockhardt Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Wockhardt SWOT Analysis
2.10.4 Wockhardt Product and Services
2.10.5 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Insulin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Insulin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Insulin Manufacturer Market Share in 2019
3.3.2 Top 6 Human Insulin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Human Insulin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Insulin Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Insulin Sales and Growth Rate (2015-2020)
4.3 Europe Human Insulin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Insulin Sales and Growth Rate (2015-2020)
4.5 South America Human Insulin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Insulin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Insulin Sales, Revenue and Market Share by Country
5.1.1 North America Human Insulin Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Insulin Revenue and Market Share by Country (2015-2020)
5.2 United States Human Insulin Sales and Growth Rate (2015-2020)
5.3 Canada Human Insulin Sales and Growth Rate (2015-2020)
5.4 Mexico Human Insulin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Insulin Sales, Revenue and Market Share by Country
6.1.1 Europe Human Insulin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Insulin Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Insulin Sales and Growth Rate (2015-2020)
6.3 UK Human Insulin Sales and Growth Rate (2015-2020)
6.4 France Human Insulin Sales and Growth Rate (2015-2020)
6.5 Russia Human Insulin Sales and Growth Rate (2015-2020)
6.6 Italy Human Insulin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Insulin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Insulin Revenue and Market Share by Regions (2015-2020)
7.2 China Human Insulin Sales and Growth Rate (2015-2020)
7.3 Japan Human Insulin Sales and Growth Rate (2015-2020)
7.4 Korea Human Insulin Sales and Growth Rate (2015-2020)
7.5 India Human Insulin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Insulin Sales and Growth Rate (2015-2020)
7.7 Australia Human Insulin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Insulin Sales, Revenue and Market Share by Country
8.1.1 South America Human Insulin Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Insulin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Insulin Sales and Growth Rate (2015-2020)
8.3 Argentina Human Insulin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Insulin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Insulin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Insulin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Insulin Sales and Growth Rate (2015-2020)
9.3 Turkey Human Insulin Sales and Growth Rate (2015-2020)
9.4 Egypt Human Insulin Sales and Growth Rate (2015-2020)
9.5 South Africa Human Insulin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Insulin Sales and Market Share by Type (2015-2020)
10.2 Global Human Insulin Revenue and Market Share by Type (2015-2020)
10.3 Global Human Insulin Price by Type (2015-2020)
11 Global Human Insulin Market Segment by Application
11.1 Global Human Insulin Sales Market Share by Application (2015-2020)
11.2 Global Human Insulin Revenue Market Share by Application (2015-2020)
11.3 Global Human Insulin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Insulin Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Insulin Market Forecast by Regions (2021-2025)
12.2.1 North America Human Insulin Market Forecast (2021-2025)
12.2.2 Europe Human Insulin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Insulin Market Forecast (2021-2025)
12.2.4 South America Human Insulin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Insulin Market Forecast (2021-2025)
12.3 Human Insulin Market Forecast by Type (2021-2025)
12.3.1 Global Human Insulin Sales Forecast by Type (2021-2025)
12.3.2 Global Human Insulin Market Share Forecast by Type (2021-2025)
12.4 Human Insulin Market Forecast by Application (2021-2025)
12.4.1 Global Human Insulin Sales Forecast by Application (2021-2025)
12.4.2 Global Human Insulin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Human Insulin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Insulin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. B. Braun Basic Information, Manufacturing Base and Competitors
Table 8. B. Braun Human Insulin Major Business
Table 9. B. Braun Human Insulin Total Revenue (USD Million) (2017-2018)
Table 10. B. Braun SWOT Analysis
Table 11. B. Braun Human Insulin Product and Services
Table 12. B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Human Insulin Major Business
Table 15. Sanofi Human Insulin Total Revenue (USD Million) (2017-2018)
Table 16. Sanofi SWOT Analysis
Table 17. Sanofi Human Insulin Product and Services
Table 18. Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biodel Basic Information, Manufacturing Base and Competitors
Table 20. Biodel Human Insulin Major Business
Table 21. Biodel Human Insulin Total Revenue (USD Million) (2017-2018)
Table 22. Biodel SWOT Analysis
Table 23. Biodel Human Insulin Product and Services
Table 24. Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Becton, Dickinson Basic Information, Manufacturing Base and Competitors
Table 26. Becton, Dickinson Human Insulin Major Business
Table 27. Becton, Dickinson Human Insulin Total Revenue (USD Million) (2017-2018)
Table 28. Becton, Dickinson SWOT Analysis
Table 29. Becton, Dickinson Human Insulin Product and Services
Table 30. Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. NOVO Nordisk Basic Information, Manufacturing Base and Competitors
Table 32. NOVO Nordisk Human Insulin Major Business
Table 33. NOVO Nordisk Human Insulin Total Revenue (USD Million) (2017-2018)
Table 34. NOVO Nordisk SWOT Analysis
Table 35. NOVO Nordisk Human Insulin Product and Services
Table 36. NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biocon Basic Information, Manufacturing Base and Competitors
Table 38. Biocon Human Insulin Major Business
Table 39. Biocon Human Insulin Total Revenue (USD Million) (2017-2018)
Table 40. Biocon SWOT Analysis
Table 41. Biocon Human Insulin Product and Services
Table 42. Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 44. Ypsomed Human Insulin Major Business
Table 45. Ypsomed Human Insulin Total Revenue (USD Million) (2017-2018)
Table 46. Ypsomed SWOT Analysis
Table 47. Ypsomed Human Insulin Product and Services
Table 48. Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Julphar Basic Information, Manufacturing Base and Competitors
Table 50. Julphar Human Insulin Major Business
Table 51. Julphar Human Insulin Total Revenue (USD Million) (2017-2018)
Table 52. Julphar SWOT Analysis
Table 53. Julphar Human Insulin Product and Services
Table 54. Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. ELI Lilly Basic Information, Manufacturing Base and Competitors
Table 56. ELI Lilly Human Insulin Major Business
Table 57. ELI Lilly Human Insulin Total Revenue (USD Million) (2017-2018)
Table 58. ELI Lilly SWOT Analysis
Table 59. ELI Lilly Human Insulin Product and Services
Table 60. ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 62. Wockhardt Human Insulin Major Business
Table 63. Wockhardt Human Insulin Total Revenue (USD Million) (2017-2018)
Table 64. Wockhardt SWOT Analysis
Table 65. Wockhardt Human Insulin Product and Services
Table 66. Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Human Insulin Sales by Manufacturer (2018-2019) (K Doses)
Table 68. Global Human Insulin Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Human Insulin Sales by Regions (2015-2020) (K Doses)
Table 70. Global Human Insulin Sales Market Share by Regions (2015-2020)
Table 71. Global Human Insulin Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Human Insulin Sales by Countries (2015-2020) (K Doses)
Table 73. North America Human Insulin Sales Market Share by Countries (2015-2020)
Table 74. North America Human Insulin Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Human Insulin Revenue Market Share by Countries (2015-2020)
Table 76. Europe Human Insulin Sales by Countries (2015-2020) (K Doses)
Table 77. Europe Human Insulin Sales Market Share by Countries (2015-2020)
Table 78. Europe Human Insulin Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Human Insulin Sales by Regions (2015-2020) (K Doses)
Table 80. Asia-Pacific Human Insulin Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Human Insulin Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Human Insulin Sales by Countries (2015-2020) (K Doses)
Table 83. South America Human Insulin Sales Market Share by Countries (2015-2020)
Table 84. South America Human Insulin Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Human Insulin Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Human Insulin Sales by Countries (2015-2020) (K Doses)
Table 87. Middle East & Africa Human Insulin Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Human Insulin Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Human Insulin Revenue Market Share by Countries (2015-2020)
Table 90. Global Human Insulin Sales by Type (2015-2020) (K Doses)
Table 91. Global Human Insulin Sales Share by Type (2015-2020)
Table 92. Global Human Insulin Revenue by Type (2015-2020) (USD Million)
Table 93. Global Human Insulin Revenue Share by Type (2015-2020)
Table 94. Global Human Insulin Sales by Application (2015-2020) (K Doses)
Table 95. Global Human Insulin Sales Share by Application (2015-2020)
Table 96. Global Human Insulin Sales Forecast by Regions (2021-2025) (K Doses)
Table 97. Global Human Insulin Market Share Forecast by Regions (2021-2025)
Table 98. Global Human Insulin Sales Forecast by Type (2021-2025) (K Doses)
Table 99. Global Human Insulin Market Share Forecast by Type (2021-2025)
Table 100. Global Human Insulin Sales Forecast by Application (2021-2025)
Table 101. Global Human Insulin Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human Insulin Picture
Figure 2. Global Sales Market Share of Human Insulin by Type in 2019
Figure 3. Insulin Analogs and Biosimilars Picture
Figure 4. Human Insulin Biologics Picture
Figure 5. Human Insulin Sales Market Share by Application in 2018
Figure 6. Short acting Picture
Figure 7. Intermediate acting Picture
Figure 8. Long acting Picture
Figure 9. Pre-mix Insulin Picture
Figure 10. Global Human Insulin Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Human Insulin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Human Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Human Insulin Sales Market Share by Manufacturer in 2019
Figure 31. Global Human Insulin Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Human Insulin Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Human Insulin Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 36. Global Human Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Human Insulin Revenue Market Share by Regions (2015-2020)
Figure 38. Global Human Insulin Revenue Market Share by Regions in 2018
Figure 39. North America Human Insulin Sales and Growth Rate (2015-2020)
Figure 40. Europe Human Insulin Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Human Insulin Sales and Growth Rate (2015-2020)
Figure 42. South America Human Insulin Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Human Insulin Sales and Growth Rate (2015-2020)
Figure 44. North America Human Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Human Insulin Sales Market Share by Countries (2015-2020)
Figure 46. North America Human Insulin Sales Market Share by Countries in 2018
Figure 47. North America Human Insulin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Human Insulin Revenue Market Share by Countries in 2018
Figure 49. United States Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Canada Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Mexico Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Europe Human Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Human Insulin Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Human Insulin Revenue Market Share by Countries in 2019
Figure 55. Germany Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. UK Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. France Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Russia Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Italy Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Asia-Pacific Human Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Human Insulin Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Human Insulin Revenue Market Share by Regions 2019
Figure 63. China Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Japan Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Korea Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. India Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. Southeast Asia Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. South America Human Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Human Insulin Sales Market Share by Countries in 2019
Figure 70. South America Human Insulin Revenue Market Share by Countries in 2019
Figure 71. Brazil Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Argentina Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Middle East and Africa Human Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Human Insulin Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Human Insulin Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Human Insulin Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Egypt Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Turkey Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. South Africa Human Insulin Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. Global Human Insulin Sales and Growth Rate (2021-2025) (K Doses)
Figure 82. Global Human Insulin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Human Insulin Market Forecast (2021-2025) (K Doses)
Figure 84. Europe Sales Human Insulin Market Forecast (2021-2025) (K Doses)
Figure 85. Asia-Pacific Sales Human Insulin Market Forecast (2021-2025) (K Doses)
Figure 86. South America Sales Human Insulin Market Forecast (2021-2025) (K Doses)
Figure 87. Middle East & Africa Sales Human Insulin Market Forecast (2021-2025) (K Doses)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
インスリンリスプロの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Insulin Lispro market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- CISインスリンの世界市場（～2026年） Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body. Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government. Market Analysis and…
- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- インスリン有効成分の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Insulin Active Pharmaceutical Ingredient market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Insu…
- インスリングラルギンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Insulin Glargine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…